Notice:
|
Suspension of shipments during Golden Week Holidays: From 30 April to 14 May, deadline 17 April.
|
|
NIG-RNAi Strains Detail |
Request : Click the "Order" button to request for this stock |
|
Stock Detail (Last Update: November 2007_FlyBase version FB2007_11) |
Stock ID |
5216R-2 |
Symbol |
Sir2 |
Full Name |
Sir2 |
CG No |
CG5216 |
Old CG No |
CG5216 |
Synonyms |
dSir2, DSir2, SIR2, Sir2L, dsir2, dmSRT406, CG5216, dSIR2, D.mel1, BEST:LD38188, l(2)05326, Sir2 |
Accession No (Link to NCBI) |
NM_058003.3 |
Inserted Chr. |
ll |
Insertional Mutation |
|
Phenotype induced by Act5C-GAL4 at 28 degrees |
lethal |
Map Viewer |
|
Reference
[Please submit your publication]
|
Avery MA, Sheehan AE, Kerr KS, Wang J, Freeman MR. Wld S requires Nmnat1 enzymatic activity and N16-VCP interactions to suppress Wallerian degeneration. J Cell Biol (2009) 184(4) 501-13
[
PubMed ID = 19237597
]
[
RRC reference
]
Kusama S, Ueda R, Suda T, Nishihara S, Matsuura ET. Involvement of Drosophila Sir2-like genes in the regulation of life span. Genes Genet Syst (2006) 81(5) 341-8
[
PubMed ID = 17159295
]
[
RRC reference
]
|
Comment |
|
Sequence (Last Update: July 10, 2007_NCBI RefSeq Release 24) |
Primer Seq. 5' |
aaggcctacatggccggaccgCTGGGCCACATTAGGTCTAAA |
Primer Seq. 3' |
aatctagaggtaccGCGAAATGCGGCATAATGCTG |
Predicted Fragment Size |
500 |
IR fragment full Seq |
0001 CNGGGcCACA TTAGGTCTAA AGATCTGGGC AACCAGGTGC CAGACACTAC GCAATTCTAT
0061 CCGCCAACTA AGTTTGATTT TGGCGCGGAA ATTCTGGCCT CAACGTCAAc agaggCAGAG
0121 GCAGAGGCAG AAGCAACAGC AACAACCACA GAACCAGCAA CAAGCGAACT TGCTGGCAAA
0181 GCAAATGGTG AAATCAAAAC AAAAACATTG GCTGCCAGGG AAGAACAAGA GATTGGCGCC
0241 AATTTGGAGC ATAAAACCAA AAATCCCACA AAGTCAATGG GCGAGGATGA AGATGACGAG
0301 GAGGAGGAGG AAGAGGACGA TGAGGAGGAG GAGGAGGACG ACGAGGAGGG AATCACCGGA
0361 ACGAGCAACG AGGATGAGGA CTCCAGCTCA AATTGCTCCT CATCCGTGGA ACCCGACTGG
0421 AAGCTGCGCT GGTTGCAACG AGAATTTTAC ACAGGTCGTG TGCCGCGCCA GGTTATTGCC
0481 AGCATTATGC CGCATTTCGC |
in silico PCR Fragment |
0001 CTGGGCCACA TTAGGTCTAA AGATCTGGGC AACCAGGTGC CAGACACTAC GCAATTCTAT
0061 CCGCCAACTA AGTTTGATTT TGGCGCGGAA ATTCTGGCCT CAACGTCAAC AGAGGCAGAG
0121 GCAGAGGCAG AAGCAACAGC AACAACCACA GAACCAGCAA CAAGCGAACT TGCTGGCAAA
0181 GCAAATGGTG AAATCAAAAC AAAAACATTG GCTGCCAGGG AAGAACAAGA GATTGGCGCC
0241 AATTTGGAGC ATAAAACCAA AAATCCCACA AAGTCAATGG GCGAGGATGA AGATGACGAG
0301 GAGGAGGAGG AAGAGGACGA TGAGGAGGAG GAGGAGGACG ACGAGGAGGG AATCACCGGA
0361 ACGAGCAACG AGGATGAGGA CTCCAGCTCA AATTGCTCCT CATCCGTGGA ACCCGACTGG
0421 AAGCTGCGCT GGTTGCAACG AGAATTTTAC ACAGGTCGTG TGCCGCGCCA GGTTATTGCC
0481 AGCATTATGC CGCATTTCGC |
Assemble Data |
5216R-2.IR_full 1 CNGGGCCACATTAGGTCTAAAGATCTGGGCAACCAGGTGCCAGACACTACGCAATTCTAT 60
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
5216R-2.in silico 1 CTGGGCCACATTAGGTCTAAAGATCTGGGCAACCAGGTGCCAGACACTACGCAATTCTAT 60
5216R-2.IR_full 61 CCGCCAACTAAGTTTGATTTTGGCGCGGAAATTCTGGCCTCAACGTCAACAGAGGCAGAG 120
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
5216R-2.in silico 61 CCGCCAACTAAGTTTGATTTTGGCGCGGAAATTCTGGCCTCAACGTCAACAGAGGCAGAG 120
5216R-2.IR_full 121 GCAGAGGCAGAAGCAACAGCAACAACCACAGAACCAGCAACAAGCGAACTTGCTGGCAAA 180
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
5216R-2.in silico 121 GCAGAGGCAGAAGCAACAGCAACAACCACAGAACCAGCAACAAGCGAACTTGCTGGCAAA 180
5216R-2.IR_full 181 GCAAATGGTGAAATCAAAACAAAAACATTGGCTGCCAGGGAAGAACAAGAGATTGGCGCC 240
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
5216R-2.in silico 181 GCAAATGGTGAAATCAAAACAAAAACATTGGCTGCCAGGGAAGAACAAGAGATTGGCGCC 240
5216R-2.IR_full 241 AATTTGGAGCATAAAACCAAAAATCCCACAAAGTCAATGGGCGAGGATGAAGATGACGAG 300
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
5216R-2.in silico 241 AATTTGGAGCATAAAACCAAAAATCCCACAAAGTCAATGGGCGAGGATGAAGATGACGAG 300
5216R-2.IR_full 301 GAGGAGGAGGAAGAGGACGATGAGGAGGAGGAGGAGGACGACGAGGAGGGAATCACCGGA 360
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
5216R-2.in silico 301 GAGGAGGAGGAAGAGGACGATGAGGAGGAGGAGGAGGACGACGAGGAGGGAATCACCGGA 360
5216R-2.IR_full 361 ACGAGCAACGAGGATGAGGACTCCAGCTCAAATTGCTCCTCATCCGTGGAACCCGACTGG 420
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
5216R-2.in silico 361 ACGAGCAACGAGGATGAGGACTCCAGCTCAAATTGCTCCTCATCCGTGGAACCCGACTGG 420
5216R-2.IR_full 421 AAGCTGCGCTGGTTGCAACGAGAATTTTACACAGGTCGTGTGCCGCGCCAGGTTATTGCC 480
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
5216R-2.in silico 421 AAGCTGCGCTGGTTGCAACGAGAATTTTACACAGGTCGTGTGCCGCGCCAGGTTATTGCC 480
5216R-2.IR_full 481 AGCATTATGCCGCATTTCGC 500
||||||||||||||||||||
5216R-2.in silico 481 AGCATTATGCCGCATTTCGC 500
|
Off-target information (Last Update: November 4, 2007_NCBI RefSeq Release 26) |
Off-target search result
cv : coefficient of variation
(0 mm hits / total siRNA count)
mm : mismatch
|
cv |
0mm |
1mm |
2mm |
3mm |
target transcript |
off target name |
100 |
482 |
16 |
100 |
208 |
NM_058003.3 |
CG5216-RA (Sir2), mRNA |
7.67 |
37 |
0 |
0 |
4 |
NM_165025.1 |
CG9828-RB, transcript variant B (DnaJ-H), mRNA |
1.65 |
8 |
29 |
72 |
100 |
NM_143338.2 |
CG12259-RA (CG12259), mRNA |
1.65 |
8 |
10 |
37 |
99 |
NM_139852.2 |
CG8591-RA (CTCF), mRNA |
1.45 |
7 |
23 |
51 |
87 |
NM_132095.2 |
CG3918-RA (CG3918), mRNA |
1.03 |
5 |
27 |
102 |
228 |
NM_132346.1 |
CG3003-RB (CG3003), mRNA |
1.03 |
5 |
20 |
47 |
78 |
NM_079842.2 |
CG17958-RA (Sry-delta), mRNA |
1.03 |
5 |
18 |
108 |
304 |
NM_132012.1 |
CG15776-RA (CG15776), mRNA |
1.03 |
5 |
13 |
42 |
88 |
NM_132074.1 |
CG3585-RA (CG3585), mRNA |
1.03 |
5 |
5 |
48 |
154 |
NM_057951.2 |
CG9210-RA, transcript variant A (Ac13E), mRNA |
1.03 |
5 |
5 |
48 |
154 |
NM_001014745.1 |
CG9210-RB, transcript variant B (Ac13E), mRNA |
0.82 |
4 |
33 |
214 |
604 |
NM_001014737.1 |
CG7107-RG, transcript variant G (up), mRNA |
0.82 |
4 |
33 |
214 |
604 |
NM_080349.2 |
CG7107-RA, transcript variant A (up), mRNA |
0.82 |
4 |
33 |
214 |
604 |
NM_167375.1 |
CG7107-RB, transcript variant B (up), mRNA |
0.82 |
4 |
33 |
214 |
604 |
NM_001014738.1 |
CG7107-RF, transcript variant F (up), mRNA |
0.82 |
4 |
33 |
214 |
604 |
NM_167376.1 |
CG7107-RD, transcript variant D (up), mRNA |
0.82 |
4 |
33 |
214 |
597 |
NM_001014739.1 |
CG7107-RE, transcript variant E (up), mRNA |
0.82 |
4 |
29 |
86 |
114 |
NM_057368.3 |
CG2621-RD, transcript variant D (sgg), mRNA |
0.82 |
4 |
8 |
24 |
42 |
NM_166973.1 |
CG12206-RB, transcript variant B (CG12206), mRNA |
0.82 |
4 |
8 |
21 |
34 |
NM_166974.1 |
CG12206-RC, transcript variant C (CG12206), mRNA |
0.82 |
4 |
8 |
21 |
34 |
NM_130704.1 |
CG12206-RA, transcript variant A (CG12206), mRNA |
0.82 |
4 |
6 |
38 |
50 |
NM_142302.1 |
CG14890-RA (CG14890), mRNA |
0.82 |
4 |
2 |
20 |
60 |
NM_137686.5 |
CG9313-RA (CG9313), mRNA |
0.62 |
3 |
21 |
62 |
145 |
NM_080335.2 |
CG2984-RA (Pp2C1), mRNA |
0.62 |
3 |
7 |
18 |
49 |
NM_141594.1 |
CG11970-RA (CG11970), mRNA |
0.62 |
3 |
5 |
26 |
130 |
NM_136634.2 |
CG1975-RA (Rep2), mRNA |
0.62 |
3 |
4 |
34 |
151 |
NM_132267.4 |
CG12109-RB (Caf1-180), mRNA |
0.41 |
2 |
35 |
72 |
112 |
NM_143802.2 |
CG8013-RA, transcript variant A (Su(z)12), mRNA |
0.41 |
2 |
35 |
72 |
110 |
NM_168826.1 |
CG8013-RB, transcript variant B (Su(z)12), mRNA |
0.41 |
2 |
24 |
41 |
97 |
NM_080371.2 |
CG2040-RC, transcript variant C (hig), mRNA |
|
|
|